Maze Therapeutics (MAZE) Company Overview

Profile

Full Name:

Maze Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 31, 2025

Indexes:

Not included

Website:

http://www.mazetx.com

Description:

Maze Therapeutics is a biotechnology company focused on developing innovative therapies for genetic diseases by leveraging genetic insights to create targeted treatments.

Key Details

Price

$12.56

Market Cap

$537.91 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.33(+3.20% YoY)

PE Ratio

-

Annual ROE

26.86%

Annual Debt To Equity

-0.13

Beta

-4.64

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with MAZE included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$12.56
MAZE price is $12.56

Price All-time High

$15.00
MAZE price is currently -16.27% below its historical high of $15.00

Price Analysts Target

-
MAZE price consensus analysts' forecast is unknown

Price Most Recent Change

-1.8%
MAZE price was down -1.8% on Feb 19, 2025

Price YTD Change

-
MAZE price ytd change is unknown

Price 3-Year Change

-
MAZE price 3-year change is unknown

Market cap

Market Cap

$537.91 M
MAZE market capitalization is $537.91 million

Market Cap 3-Year Change

-
MAZE market capitalization 3-year change is unknown

Market Cap All-time High

$642.40 M
MAZE market capitalization is currently -16.27% below its historical high of $642.40 million

Market Cap Sector Rank

68.13%
MAZE market capitalization is higher than 68.13% of companies in Healthcare sector

Technical

Beta

-4.64
MAZE beta is -4.64

200-day SMA

$12.79
MAZE price is currently -1.84% below its 200-day simple moving average

14-day RSI

37.11
MAZE 14-day relative strength index is 37.11

30-day Relative Volume

0.52
MAZE 30-day relative volume is 0.52

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
MAZE annual revenue value is unknown

Annual Revenue Analysts Estimate

-
MAZE annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
MAZE annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
MAZE annual revenue is unknown

Profit

Annual Gross Profit

-
MAZE annual gross profit value is unknown

Annual Gross Margin

-
MAZE annual gross profit margin value is unknown

Annual Operating Profit

-$98.55 M
MAZE annual operating income is -$98.55 million

Annual Operating Margin

-
MAZE annual operating profit margin value is unknown

Annual Net Income

-$100.42 M
MAZE annual net profit is -$100.42 million

Annual Net Margin

-
MAZE annual net profit margin value is unknown

EPS

Annual EPS

-$0.33
MAZE annual earnings per share is -$0.33

Annual EPS Analysts Estimate

-
MAZE annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+3.2%
MAZE annual earnings per share is up +3.2% year-on-year

Annual EPS Sector Rank

-
MAZE annual earnings per share is unknown

ROA & ROE

Annual ROA

-140.43%
MAZE annual return on assets is -140.43%

Annual ROE

26.86%
MAZE annual return on equity is 26.86%

EBIT & EBITDA

Annual EBIT

-$98.55 M
MAZE annual earnings before interest & taxes is -$98.55 million

Annual EBITDA

-$94.46 M
MAZE annual EBITDA is -$94.46 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MAZE price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MAZE price to earnings ratio is unknown

PB Ratio

PB Ratio

-1.89
MAZE price to book ratio is -1.89

PB Ratio Sector Rank

7.64%
MAZE price to book ratio is higher than 7.64% of companies in Healthcare sector

PS Ratio

PS Ratio

215.16
MAZE price to sales ratio is 215.16

PS Ratio Sector Rank

96.4%
MAZE price to sales ratio is higher than 96.4% of companies in Healthcare sector

Enterprise value

Enterprise Value

$467.46 M
MAZE enterprise value is $467.46 million

Enterprise Value Sector Rank

66.92%
MAZE enterprise value is higher than 66.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.27
MAZE EV/EBITDA is -10.27

EV/EBITDA Sector Rank

14%
MAZE EV/EBITDA is higher than 14% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.09
MAZE annual current ratio is 2.09

Annual Quick Ratio

-
MAZE annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.13
MAZE annual debt to equity ratio is -0.13

Annual Interest Coverage Ratio

-
MAZE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MAZE piotroski f-score value is unknown

Altman Z-Score

-
MAZE altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$71.50 M
MAZE annual total assets is $71.50 million

Annual Non Current Assets

$37.39 M
MAZE annual long term assets is $37.39 million

Annual Current Assets

$34.11 M
MAZE annual total current assets is $34.11 million

Annual Cash & Cash Equivalents

$29.16 M
MAZE annual cash & cash equivalents is $29.16 million

Equity

Annual Book Value

-$373.85 M
MAZE annual book value is -$373.85 million

Annual Working Capital

$17.79 M
MAZE annual working capital is $17.79 million

Liabilities

Annual Total Liabilities

$445.35 M
MAZE annual total liabilities is $445.35 million

Annual Total Long Term Liabilities

$429.04 M
MAZE annual total long term liabilities is $429.04 million

Annual Current Liabilities

$16.32 M
MAZE annual total current liabilities is $16.32 million

Annual Accounts Payable

$2.02 M
MAZE annual accounts payable is $2.02 million

Debt

Annual Total Debt

$49.62 M
MAZE annual total debt is $49.62 million

Annual Total Debt 1-Year Change

+54.81%
MAZE annual total debt is up +54.81% year-on-year

Annual Long Term Debt

$45.13 M
MAZE annual long term debt is $45.13 million

Annual Short Term Debt

$4.49 M
MAZE annual short term debt is $4.49 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$98.55 M
MAZE annual total expenses is $98.55 million

Annual Operating Expenses

$98.55 M
MAZE annual total operating expenses is $98.55 million

Annual Cost Of Goods Sold

-
MAZE annual cost of goods sold value is unknown

Annual SGA

$24.61 M
MAZE annual SGA is $24.61 million

Annual D&A

$4.09 M
MAZE annual depreciation & amortization is $4.09 million

Annual Interest Expense

-
MAZE annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$86.83 M
MAZE annual cash flow from operations is -$86.83 million

Annual CFO 1-Year Change

+12.48%
MAZE annual cash flow from operations is up +12.48% year-on-year

Annual CFI

-$441.00 K
MAZE annual cash flow from investing activities is -$441.00 thousand

Annual CFI 1-Year Change

+86.09%
MAZE annual cash flow from investing activities is up +86.09% year-on-year

Annual CFF

$16.39 M
MAZE annual cash flow from financing activities is $16.39 million

Annual CFF 1-Year Change

+848.21%
MAZE annual cash flow from financing activities is up +848.21% year-on-year

Free CashFlow

Annual FCF

-$87.27 M
MAZE annual free cash flow is -$87.27 million

Annual FCF 1-Year Change

+13.74%
MAZE annual free cash flow is up +13.74% year-on-year

CAPEX

Annual CAPEX

-
MAZE annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
MAZE annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

MGTX logo
MeiraGTx Holdings (MGTX)
CGEM logo
Cullinan Oncology (CGEM)
OMI logo
Owens & Minor (OMI)
KALV logo
KalVista Pharmaceuticals (KALV)
VREX logo
Varex Imaging (VREX)
ALLO logo
Allogene Therapeutics (ALLO)
AUTL logo
Autolus Therapeutics (AUTL)
FLGT logo
Fulgent Genetics (FLGT)
PACB logo
Pacific Biosciences of California (PACB)

FAQ

  • What is the ticker symbol for Maze Therapeutics?
  • Does Maze Therapeutics pay dividends?
  • What sector is Maze Therapeutics in?
  • What industry is Maze Therapeutics in?
  • What country is Maze Therapeutics based in?
  • When did Maze Therapeutics go public?
  • Is Maze Therapeutics in the S&P 500?
  • Is Maze Therapeutics in the NASDAQ 100?
  • Is Maze Therapeutics in the Dow Jones?
  • When does Maze Therapeutics report earnings?

What is the ticker symbol for Maze Therapeutics?

The ticker symbol for Maze Therapeutics is NASDAQ:MAZE

Does Maze Therapeutics pay dividends?

No, Maze Therapeutics does not pay dividends

What sector is Maze Therapeutics in?

Maze Therapeutics is in the Healthcare sector

What industry is Maze Therapeutics in?

Maze Therapeutics is in the Biotechnology industry

What country is Maze Therapeutics based in?

Maze Therapeutics is headquartered in United States

When did Maze Therapeutics go public?

Maze Therapeutics's initial public offering (IPO) was on January 31, 2025

Is Maze Therapeutics in the S&P 500?

No, Maze Therapeutics is not included in the S&P 500 index

Is Maze Therapeutics in the NASDAQ 100?

No, Maze Therapeutics is not included in the NASDAQ 100 index

Is Maze Therapeutics in the Dow Jones?

No, Maze Therapeutics is not included in the Dow Jones index

When does Maze Therapeutics report earnings?

The date for Maze Therapeutics's next earnings report has not been announced yet